Biotech Values

[DewDiligence]

Re: Forbes:

>> Zina the author of the article mentions the wet and dry form of amd and that the dry form can turn to the wet form. She didn't make the connection that since squalamine works systemically it may either prevent the second eye from ever becoming the wet form or even if the eye does progress it may take care of the problem before the disease progresses and causes too much damage to the eye so that it can't be repaired. <<

She needs to leave some good stuff for the next article –the one that will be written about the partnership deal for Squalamine

Overall, I thought it was a fairly well-written article, although it was clearly too dismissive of the shortcomings in the recently released Macugen data.